Back

External Validation of HASBLED and ORBIT bleeding risk scores in Wales-AF population

26 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: scores (2) Scores ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mrs Fatemeh TORABI

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
AF in TAVR patients: double trouble means double care
Doctor C. Oliveira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Validation of the PRECISE-DAPT score in a population-based sample of patients undergoing percutaneous coronary intervention with stent implantation
Mr C. Lim (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Improving risk stratification of recurrent myocardial infarction in a large real-world dataset using machine learning
Professor Z. Vered (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Clinician-reported EHRA and NYHA scores only moderately reflect patient-reported quality of life in atrial fibrillation and heart failure
Doctor J. Van De Pol (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
Utility of a polygenic risk score for incident CHD: interplay with lifestyle in a multi-ethnic cohort of more than 60,000 individuals
Doctor C. Iribarren (Oakland, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: scores (2)

The Event

Event poster

ESC Congress 2023

26 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation
thumbnail
Congress Presentation
Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial
thumbnail
Congress Session
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources